Breast cancer is the most common cancer in women, accounting for about one-third of cancer cases in women and approximately 14% of cancer-related death in females in the worldwide. It is of great importance to detect breast cancer in the early stage and avoiding overtreatment in patients who only receive a modest benefit, while suffering from toxic side effects, so aiming early detection, diagnostic strategies are important. Biomarkers that are found in blood, urine or body tissues are mostly useful in evaluating the progression of the disease status after initial chemotherapy and radiotherapy to monitor subsequent treatment strategies. In this review, we discuss the importance of established prognostic factors and predictive biomar...
The amount of published literature on biomarkers has exponentially increased over the last two deca...
Breast cancer, being the most common type of malignant diseases, remains a significant challenge for...
International audienceA major challenge of breast cancer research is the identification of accurate ...
Breast cancer is the most common cancer amongst women in the United States and around the world. Alt...
Breast cancer is one of the most common and leading causes of cancer death in women. Early diagnosis...
One of the main priorities in modern oncology is the identification and clinical application of biom...
Breast cancer screening and presurgical diagnosis are currently based on mammography, ultrasound and...
Breast cancer is considered the most commonly diagnosed tumors. Biomarkers used for the diagnosis an...
Breast cancer is one of the most frequent malignancies among women worldwide. Methods for screening ...
Breast cancer is the most frequently diagnosed cancer among women and a leading cause of cancer-rela...
Technological developments are propelling medical diagnostics forward at unprecedented rates. Advanc...
More than 13,000 women are diagnosed with breast cancer in the Netherlands each year. 86% of breast ...
Predictive biomarkers can guide treatment decisions in breast cancer. Many studies are undertaken to...
Breast cancer is a complex disease which is found as the second cause of cancer-associated death amo...
Breast cancer is the most frequent cancer among women, and represents the second highest number of d...
The amount of published literature on biomarkers has exponentially increased over the last two deca...
Breast cancer, being the most common type of malignant diseases, remains a significant challenge for...
International audienceA major challenge of breast cancer research is the identification of accurate ...
Breast cancer is the most common cancer amongst women in the United States and around the world. Alt...
Breast cancer is one of the most common and leading causes of cancer death in women. Early diagnosis...
One of the main priorities in modern oncology is the identification and clinical application of biom...
Breast cancer screening and presurgical diagnosis are currently based on mammography, ultrasound and...
Breast cancer is considered the most commonly diagnosed tumors. Biomarkers used for the diagnosis an...
Breast cancer is one of the most frequent malignancies among women worldwide. Methods for screening ...
Breast cancer is the most frequently diagnosed cancer among women and a leading cause of cancer-rela...
Technological developments are propelling medical diagnostics forward at unprecedented rates. Advanc...
More than 13,000 women are diagnosed with breast cancer in the Netherlands each year. 86% of breast ...
Predictive biomarkers can guide treatment decisions in breast cancer. Many studies are undertaken to...
Breast cancer is a complex disease which is found as the second cause of cancer-associated death amo...
Breast cancer is the most frequent cancer among women, and represents the second highest number of d...
The amount of published literature on biomarkers has exponentially increased over the last two deca...
Breast cancer, being the most common type of malignant diseases, remains a significant challenge for...
International audienceA major challenge of breast cancer research is the identification of accurate ...